ArticleProstate international2022

Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer.

Shigetomo Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.